Diagnostic ability of Elisar ZEST algorithm for glaucoma in chennai main hospital

Elisar Life Sciences pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年2月6日

研究概览

暂无简介。

•Inclusion into the control group:
•Normal subjects will be recruited who has:
•1.Intraocular pressure (IOP) in AT < 21 mmHg,
•2.Optic disc examination graded as normal.
•3.No family history of glaucoma.
•Inclusion into glaucoma group:
•1.Glaucoma diagnosis will be based on the presence of typical glaucomatous optic disc damage (i. e. Cup: disc ratio > 0.6, localized rim loss, optic disc hemorrhage, or cup-to-disc asymmetry > 0.2),
•2.IOP in AT > 21 mmHg.
•3.Glaucoma of any type without any secondary complications.
•4.Glaucomatous Optic Neuropathy (GON) detection by glaucoma expert.

•1.Subjects who have undergone ocular surgeries, with ocular disease, amblyopia, neurological disorders will be excluded from the study.
•2.Subjects will be excluded with systemic or ocular disease other than glaucoma that might interfere with visual field results.
•3.The cataract greater than moderate lens opacification will be excluded from the study as per the LOCS III grading system.
•4.Using a miotic drug will be excluded from the study

发起方

Elisar Life Sciences pvt Ltd